GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Debt-to-EBITDA

Big Pharma Split (TSX:PRM.PR.A.PFD) Debt-to-EBITDA


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Debt-to-EBITDA?

Debt-to-EBITDA does not apply to banks.


Big Pharma Split (TSX:PRM.PR.A.PFD) Business Description

Traded in Other Exchanges
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.